2.5MM Aggressive Blade Known as a Sinuscopic Shaver Blade, this device is composed of a metal cu...

FDA Device Recall #Z-1247-2014 — Class II — March 18, 2014

Recall Summary

Recall Number Z-1247-2014
Classification Class II — Moderate risk
Date Initiated March 18, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Stryker Instruments Div. of Stryker Corporation
Location Portage, MI
Product Type Devices
Quantity 90 units

Product Description

2.5MM Aggressive Blade Known as a Sinuscopic Shaver Blade, this device is composed of a metal cutter and plastic drive shaft that goes into a metal housing supported by a plastic hub. ENT Precision Cutter, Aggressive, ESSxlHUMMER 4, Rx Only It is used for ENT procedures and functions by means of rotation when adapted to a handpiece and console. Through the rotation, the necessary tissue is resected as required by the user. The blade housing has an etching line guide that starts with a straight line and along with a scale from 1cm to 7cm in 1cm increments that serves the doctor as a guide by indicating how far the device is being introduced into the surgical area.

Reason for Recall

Stryker Instruments is voluntarily recalling the single use 2.5MM Aggressive Blade because the line on the affected part (P/N 5290-928-000, Lot #13280CG2) was a straight line without a number scale or logo. The line required for this part number includes a number scale that goes from 1cm  7cm.

Distribution Pattern

US Distribution including the states of NV, CA, WA, TN, OR, SD, ID, IN and CO., and Internationally to Malaysia

Lot / Code Information

P/N 5290-628-000, Lot #13280CG2

Other Recalls from Stryker Instruments Div. of Stryker C...

Recall # Classification Product Date
Z-1452-2022 Class II SurgiCount+ System Application, Software Versio... Jun 15, 2022
Z-0431-2021 Class II Stryker Zyphr Disposable Cranial Perforator, La... Oct 16, 2020
Z-1807-2020 Class II Neptune E-SEP 165mm Blade Electrode, Catalog Nu... Mar 26, 2020
Z-1402-2022 Class II Triton Canister System (finished part numbers F... Jan 22, 2020
Z-1097-2020 Class II SafeAir Telescopic Smoke Evacuation Pencil, Pr... Jan 13, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.